ADVB Wichtige Statistiken
Hoch
18.73
Öffnen
8.32
Volumen
23.55M
Niedrig
8.08
Vorheriger Schlusskurs
7.08
Handelswert
312.10M
52W-Hoch
18.73
Rel. Volumen
5.794
Amplitude (%)
150.42%
52W-Tief
3.61
Umsatzrate
1425.97%
Marktkapitalisierung
11.69M
KGV (TTM)
44.47
KGV (Jährlich)
--
KBV
1.27
KUV
--
Gewinn je Aktie (EPS)
0.159
Dividende (TTM)
0
Dividendenrendite
0.00%
Ausstehende Aktien
1.65M
Währung
USD
ADVB Preis-Performance
7 Tag
30 Tag
90 Tag
180 Tag
Seit Jahresbeginn
1 Jahr
ADVB Moneyflow-Verteilung
ADVB Tägliches Leerverkaufsvolumen
ADVB Short-Interest-Historie
ADVB Aktien-Snapshot
As of 2026-07-22, the Advanced Biomed Inc. (ADVB) stock price today is 12.41. Based on this price, the company has a market capitalization of $11.69M, with a P/E ratio of 44.47.
On 2026-07-22, ADVB traded between 8.08 and 18.73. Today’s stock price is 53.59% above the daily low and 33.74% below the daily high, placing ADVB in der Mitte von its most recent trading range.
Trading volume currently stands at 23.55M, compared with an average daily volume of 4.06M. This suggests that trading activity is deutlich über dem üblichen Niveau than usual.
Over the past year, Advanced Biomed Inc. shares have traded between 3.61 and 18.73. At today’s price, ADVB is 243.77% above its 52-week low and 33.74% below its 52-week high.
ADVB Verwandte Nachrichten
Über ADVB
Firmenname
Advanced Biomed Inc.
Sektor
Health Technology
Branche
Biotechnology
Börsen
Nasdaq
Anzahl der Beschäftigten
31
Losgröße
100
Offizielle Website
Währung
USD
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
Related Stocks
ADVB FAQ
© 2026 CoinGlass, all rights reserved
